Nephrocare Health Services Ltd
Nephrocare Health Services Ltd (NEPHROPLUS) last reported results for the quarter ended Jun 2026, with sales of ₹282 crore and net profit of ₹32 crore. The stock last traded at ₹633, a market capitalisation of ₹6,361 crore, on a P/E of 74.7. Over the past 52 weeks the stock has ranged between ₹445 and ₹782. Figures are as of 6 Oct 2026 and are not real time.
Nephrocare Health Services Ltd share price and key metrics
- Current price
- ₹633
- Market cap
- ₹6,361 cr
- Stock P/E
- 74.7
- Book value
- ₹111
- ROE
- 8.83%
- ROCE
- 15.3%
- Dividend yield
- 0.00%
- 52w high / low
- 782/445
Metrics as of 6 Oct 2026. Not real time.
Track Nephrocare Health Services Ltd
Cruxal reads every Nephrocare Health Services Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Nephrocare Health Services Ltd growth and returns
- 10 Years
- %
- 5 Years
- 28%
- 3 Years
- 32%
- TTM
- 32%
- 10 Years
- %
- 5 Years
- 162%
- 3 Years
- 103%
- TTM
- 12%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- 6%
- 3 Years
- 10%
- Last Year
- 9%
Nephrocare Health Services Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹282 cr, up 23.7% from ₹228 cr a year earlier. Net profit was ₹32 cr, up 33.3% year on year.
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 197 | 219 | 228 | 246 | 260 | 266 | 282 |
| Expenses | 153 | 168 | 180 | 182 | 199 | 215 | 221 |
| Operating profit | 44 | 51 | 48 | 64 | 61 | 51 | 60 |
| OPM % | 22% | 23% | 21% | 26% | 23% | 19% | 21% |
| Other income | 5 | 4 | 7 | 4 | 3 | 12 | 7 |
| Interest | 5 | 6 | 6 | 45 | 6 | 3 | 2 |
| Depreciation | 18 | 19 | 20 | 23 | 22 | 26 | 25 |
| Profit before tax | 26 | 30 | 29 | -1 | 36 | 33 | 41 |
| Tax % | 24% | 17% | 17% | 1,427% | 11% | 9% | 22% |
| Net profit | 20 | 25 | 24 | -9 | 32 | 30 | 32 |
| EPS (₹) | 96.50 | 119.30 | 13.10 | -5.24 | 3.21 | 3.03 | 3.19 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Nephrocare Health Services Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 286 | 318 | 437 | 566 | 756 | 999 | 1,053 |
| Operating profit | 37 | 16 | 49 | 101 | 167 | 225 | 236 |
| OPM % | 13% | 5% | 11% | 18% | 22% | 23% | 22% |
| Net profit | 1 | -21 | -12 | 35 | 67 | 77 | 85 |
| EPS (₹) | 3.40 | -106.93 | -58.69 | 169.82 | 321.87 | 7.66 | 4.19 |
TTM is the trailing twelve months to the most recent quarter.
Nephrocare Health Services Ltd balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 2 | 2 | 2 | 20 |
| Reserves | 245 | 391 | 384 | 409 | 579 | 1,096 |
| Borrowings | 140 | 119 | 200 | 271 | 261 | 80 |
| Other liabilities | 42 | 59 | 81 | 124 | 153 | 271 |
| Total liabilities | 428 | 571 | 666 | 806 | 994 | 1,467 |
| Fixed assets | 192 | 205 | 239 | 356 | 396 | 517 |
| CWIP | 2 | 43 | 34 | 1 | 6 | 6 |
| Investments | 0 | 0 | 0 | 0 | 51 | 178 |
| Other assets | 234 | 322 | 393 | 449 | 542 | 767 |
| Total assets | 428 | 571 | 666 | 806 | 994 | 1,467 |
As reported by the company. Total assets equal total liabilities by construction.
Nephrocare Health Services Ltd cash flow
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 32 | 14 | 11 | 72 | 135 | 233 |
| Cash from investing | -62 | -130 | -76 | -52 | -125 | -392 |
| Cash from financing | 36 | 121 | 60 | 27 | 54 | 157 |
| Net cash flow | 5 | 6 | -4 | 47 | 65 | -2 |
| Free cash flow | -29 | -64 | -62 | -8 | 35 | 113 |
| CFO / operating profit | 49% | 119% | 14% | 80% | 82% | 116% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Nephrocare Health Services Ltd operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | — | -4% | 1% | 8% | 14% | 15% |
| Debtor days | 101 | 123 | 132 | 131 | 129 | 116 |
| Inventory days | 65 | 50 | 67 | — | — | — |
| Days payable | 56 | 70 | 63 | — | — | — |
| Cash conversion cycle | 110 | 103 | 137 | 131 | 129 | 116 |
| Working capital days | 26 | 55 | 19 | 56 | 27 | 42 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Nephrocare Health Services Ltd shareholding pattern
Promoters held 63.85% at Jun 2026, broadly unchanged since Dec 2025. FIIs 8.78% and DIIs 9.05%.
| % held | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Promoters | 63.85% | 63.85% | 63.85% |
| FIIs | 9.30% | 9.94% | 8.78% |
| DIIs | 8.10% | 8.64% | 9.05% |
| Public | 18.74% | 17.56% | 18.30% |
| No. of shareholders | 67,416 | 43,409 | 44,091 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Nephrocare Health Services Ltd corporate filings
- We are enclosing herewith a certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30th September, 2026 received from M/s. KFIN Technologies Limited.Company Updatelow impact
- Polar Capital Funds Increases Stake in Nephrocare Health Services Ltd to 8.31% via Off-Market PlacingInsider Trading / SASThigh impact
Cruxal's analysis: Nephrocare Health Services Ltd has witnessed a significant increase in institutional…
Read the full analysis - Trading window shall be closed till 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter and half yearly ended September 30, 2026.Insider Trading / SASTlow impact
- Nephrocare Health Services Ltd schedules investor conference callCompany Updatelow impact
Cruxal's analysis: Nephrocare Health Services Ltd has announced an investor conference call pursuant to…
Read the full analysis - Nephrocare Health Services Limited (NephroPlus) Receives Credit Rating Upgrade to IND AA-/StableCompany Updatehigh impact
Cruxal's analysis: Nephrocare Health Services Limited has received a credit rating upgrade from India…
Read the full analysis - Nephrocare Health Services Ltd announces rationalization and consolidation of Philippine step-down subsidiariesCompany Updatelow impact
Cruxal's analysis: Nephrocare Health Services Ltd has initiated a restructuring process involving the…
Read the full analysis - Nephrocare Health Services subsidiary acquires dialysis center in the PhilippinesCompany Updatemedium impact
Cruxal's analysis: Nephrocare Health Services, Philippines Inc., a step-down wholly owned subsidiary, has…
Read the full analysis - Nephrocare Health Services Ltd announces grant of ESOPs under 2026 schemeCompany Updatelow impact
Cruxal's analysis: The company has formally approved the grant of Employee Stock Options (ESOPs) under the…
Read the full analysis - Nephrocare Health Services to acquire 100% stake in Kazakhstan-based Dialysis Center Almaty for INR 11.64 croreCompany Updatemedium impact
Cruxal's analysis: Nephrocare Health Services Limited, through its overseas step-down subsidiary NPHSK LLP…
Read the full analysis - Nephrocare Health Services Ltd reports receipt of tax demand following tax auditCompany Updatelow impact
Cruxal's analysis: Nephrocare Health Services Ltd has disclosed the receipt of a tax demand notice following…
Read the full analysis - Nephrocare Health Services Reports Strong Q1 FY27 Growth with 23.7% Revenue Increase and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Nephrocare Health Services Limited reported a robust Q1 FY27 performance with revenue…
Read the full analysis - Nephrocare Health Services subsidiary acquires dialysis centre in the PhilippinesCompany Updatemedium impact
Cruxal's analysis: Nephrocare Health Services, Philippines Inc., a step-down wholly-owned subsidiary, has…
Read the full analysis - Nephrocare Health Services Limited concludes 17th AGM; shareholders approve ESOP scheme and promoter incentive arrangementAGM/EGMlow impact
Cruxal's analysis: Nephrocare Health Services Limited has successfully concluded its 17th Annual General…
Read the full analysis - Nephrocare Health Services Ltd schedules investor conference callCompany Updatelow impact
Cruxal's analysis: Nephrocare Health Services Ltd has issued a formal intimation under Regulation 30 of the…
Read the full analysis - Nephrocare Health Services subsidiary acquires dialysis centre in the PhilippinesCompany Updatemedium impact
Cruxal's analysis: Nephrocare Health Services, Philippines Inc., a stepdown wholly-owned subsidiary, has…
Read the full analysis - Nephrocare Health Services clarifies subsidiary structure for Kazakhstan operationsCompany Updatelow impact
Cruxal's analysis: Nephrocare Health Services Limited has issued a formal clarification regarding the…
Read the full analysis - Nephrocare Health Services Limited concludes 17th AGM; approves ESOP scheme and promoter incentive arrangementsAGM/EGMlow impact
Cruxal's analysis: Nephrocare Health Services Limited has successfully concluded its 17th Annual General…
Read the full analysis - Nephrocare Health Services Limited Files Audio Recording of Q1FY27 Earnings Conference CallCompany Updatelow impact
Cruxal's analysis: Nephrocare Health Services Limited has formally submitted the audio recording of its…
Read the full analysis - Nephrocare Health Services Ltd files Monitoring Agency Report for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Nephrocare Health Services Ltd has submitted its Monitoring Agency Report for the quarter…
Read the full analysis - Nephrocare Health Services Reports Strong Q1FY27 Results with 23.7% Revenue Growth and Significant Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Nephrocare Health Services Limited (NephroPlus) delivered a robust performance for…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.